心血管磁共振用于心脏移植后的排斥监测

Chris Anthony1, Muhammad Imran1, Jim Pouliopoulos1,2,3

  • 1Heart and Lung Transplant Unit (C.A., M.I., J.P., S.E., J.I., M.R.Q., R.M.G., J.M., C.H., E.K., K.M., A.M.K., C.S.H., P.S.M., A.J.), St. Vincent's Hospital, Sydney, Australia.

Circulation
|May 27, 2022
PubMed
概括

心血管磁共振 (CMR) 为心脏移植患者的急性心脏异位排斥 (ACAR) 提供了可行的非侵入性监测策略. 与传统心脏内膜活检 (EMB) 相比,这种方法显著减少了住院和感染.